Provided by Tiger Trade Technology Pte. Ltd.

Warren Buffett holdings

3,184.35
+24.640.78%
Number of Gainers:22
Number of Losers:13
Number of Flat:- -
PE:- -
High:3,191.24
Open:3,159.88
Low:3,159.53
Close:3,159.71
Volume:295.92M
Turnover:37.73B
Market Cap:11.33T
Float Cap:10.77T

Loading ...

CME Group Streamlines Capital Structure With Charter Update

TIPRANKS
·
Sep 26

KKR Reports More Than $750 Million in Q3 Monetization Income

MT Newswires Live
·
Sep 26

Top News Today: U.S. Stocks Rise to End Volatile Week

Dow Jones
·
Sep 26

Wall Street Closes Higher as All Three Major Indexes Gain and Post Weekly Advances, Shrugging Off Bond Selloff; Apple Sets Another Record

Deep News
·
Sep 26

W.W. Grainger Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26

General Motors Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

Coca-Cola Taps Monster Exec as President of North American Unit

Dow Jones
·
Sep 26

Merck, Daiichi Sankyo Withdraw US Application for Lung Cancer Drug

Reuters
·
Sep 26

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

VOO ETF Gains 0.5%

Dow Jones
·
Sep 26

ConocoPhillips Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26

Merck, Daiichi Sankyo voluntarily withdraw BLA for ifinatamab deruxtecan

TIPRANKS
·
Sep 26

Citigroup Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

Microsoft Corp. Stock Advances 3.7%, Outperforms Peers

Dow Jones
·
Sep 26

Pool Corporation Announces Director Appointment

THOMSON REUTERS
·
Sep 26

Merck & Co - Daiichi Sankyo and Merck Withdraw Bla for Ifinatamab Deruxtecan in Es-Sclc in U.S.

THOMSON REUTERS
·
Sep 26

Merck & Co - Withdrawal Based on FDA Discussions; Phase 2 Data Do not Satisfy Approval Requirements

THOMSON REUTERS
·
Sep 26

Merck & Co - Patient Enrollment Continues in Ideate-Lung02 Phase 3 Trial for Ifinatamab Deruxtecan

THOMSON REUTERS
·
Sep 26

Merck & Co - Two Additional Phase 3 Trials Underway for Ifinatamab Deruxtecan in Crpc and Escc

THOMSON REUTERS
·
Sep 26

Stock Market Today: SPY, QQQ Rallied after Trump-Xi Summit Concluded; Oil Slipped 2%

TIPRANKS
·
Sep 26